Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -128,436 | -87,435 | 29,403 | -45,532 | -21,824 |
| Depreciation Amortization | 6,797 | 3,035 | 9,326 | 6,942 | 4,590 |
| Accounts receivable | -3,099 | 3,931 | -1,603 | 3,428 | 3,888 |
| Accounts payable and accrued liabilities | 1,403 | 153 | -5,072 | -2,955 | -1,039 |
| Other Working Capital | 4,853 | -869 | -3,286 | 94,098 | 95,542 |
| Other Operating Activity | 79,666 | 58,081 | -9,265 | -22,215 | -29,583 |
| Operating Cash Flow | $-38,816 | $-23,104 | $19,503 | $33,766 | $51,574 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -450,668 | 8,571 | -218,283 | -119,855 | -56,750 |
| PPE Investments | -1,970 | -401 | -1,039 | -972 | -436 |
| Investing Cash Flow | $-452,638 | $8,170 | $-219,322 | $-120,827 | $-57,186 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 895,536 | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | N/A | -16,000 | -16,000 | -16,000 |
| Common Stock Issued | 25,311 | 22,343 | 233,839 | 107,962 | 827 |
| Other Financing Activity | -52,246 | 843,378 | 34,000 | 34,000 | 34,000 |
| Financing Cash Flow | $868,601 | $865,721 | $251,839 | $125,962 | $18,827 |
| Beginning Cash Position | 85,947 | 85,947 | 33,927 | 33,627 | 33,627 |
| End Cash Position | 463,094 | 936,734 | 85,947 | 72,528 | 46,842 |
| Net Cash Flow | $377,147 | $850,787 | $52,020 | $38,901 | $13,215 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,816 | -23,104 | 19,503 | 33,766 | 51,574 |
| Capital Expenditure | -1,970 | -401 | -1,039 | -972 | -436 |
| Free Cash Flow | -40,786 | -23,505 | 18,464 | 32,794 | 51,138 |